While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

The Centers for Disease Control and Prevention abruptly ordered its staff to cease all collaboration with the World Health ...

Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human ...

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it ...

Moderna’s efforts to develop a range of mRNA ... hospitalised with influenza to see if they are suffering from bird flu, says CDC. Join the conversation, on Tuesday 28th January @ 10 am ET ...

The grant covers further development of candidates against avian ... Moderna to be one of the preferred providers of vaccines in the event of a larger influenza outbreak during the next flu ...

The first human bird flu death in the US has Moderna's vaccine development in focus for investors this week. Recently, Zacks.com users have been paying close attention to Novavax (NVAX).